Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
204 studies found for:    "Eye Diseases, Hereditary" OR "Peters plus syndrome"
Show Display Options
Rank Status Study
21 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
22 Unknown  Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
Conditions: Fuch's Dystrophy;   Corneal Disorders;   Prior Surgery
Intervention:
23 Unknown  Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
Condition: Thyroid-associated Ophthalmopathy
Intervention: Drug: subconjunctival triamcinolone injection
24 Recruiting Comparison of Two Techniques in Achieving Corneal Graft
Condition: Fuch's Endothelial Dystrophy
Intervention: Procedure: Endothelial descemet membrane graft
25 Completed Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
Conditions: Aniridia;   Eye Abnormality;   Ocular Hypertension;   Open Angle Glaucoma
Intervention:
26 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
27 Not yet recruiting An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
Condition: Choroideremia
Intervention: Genetic: rAAV2.REP1 vector
28 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
29 Terminated The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia
Condition: Choroideremia
Intervention: Drug: Simvastatin
30 Recruiting Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Conditions: Thyroid Associated Ophthalmopathies;   Graves´ Ophthalmopathy;   Thyroid Eye Disease
Interventions: Drug: Tocilizumab (RoActemra®);   Drug: Sterile 0.9% Sodium Chloride
31 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
32 Completed Positive Angle Kappa
Condition: Aniridia
Intervention:
33 Completed A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema
Conditions: Fuchs Dystrophy;   Corneal Edema
Intervention: Procedure: Corneal transplantation
34 Enrolling by invitation Advanced Characterization of Autosomal Dominant Optic Atrophy
Condition: Optic Atrophy, Autosomal Dominant
Intervention:
35 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
36 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
37 Terminated
Has Results
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Conditions: Hermansky-Pudlak Syndrome (HPS);   Pulmonary Fibrosis;   Oculocutaneous Albinism;   Platelet Storage Pool Deficiency;   Metabolic Disease
Interventions: Drug: Losartan;   Drug: Zileuton;   Drug: N-Acetylcysteine;   Drug: Pravastatin;   Drug: Erythromycin
38 Completed Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy
Conditions: Graves' Disease;   Graves' Ophthalmopathy
Intervention:
39 Completed Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
Conditions: Graves' Dysthyroid Ophthalmopathy;   Thyroid Related Orbitopathy
Intervention: Drug: Rituximab
40 Completed A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)
Condition: Optic Atrophy, Hereditary, Leber
Intervention: Drug: curcumin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years